Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
297 studies found for:    Open Studies | "Macular Degeneration"
Show Display Options
Rank Status Study
21 Recruiting Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.
Condition: Neovascular Age-related Macular Degeneration
Intervention: Drug: Aflibercept (EYLEA)
22 Unknown  Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-Related Macular Degeneration
Condition: Neovascular Age-Related Macular Degeneration
Intervention: Drug: Bevacizumab (Avastin), Verteporfin (Visudyne)
23 Recruiting Prospective Randomized Trial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
Condition: Exudative Age-related Macular Degeneration
Interventions: Drug: 24GyE proton and Anti-VEGF;   Drug: 16GyE and anti-VEGF;   Drug: Sham Irradiation and anti-VEGF
24 Recruiting Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes
Condition: Age Related Macular Degeneration
Intervention: Drug: Ranibizumab
25 Unknown  Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Device: Ocular Brachytherapy
26 Unknown  A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: ALG 1001
27 Recruiting Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration
Condition: Dry Macular Degeneration
Intervention: Biological: Adipose Derived Stem Cells
28 Not yet recruiting Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
Condition: Wet Age-related Macular Degeneration
Interventions: Drug: Bevacizumab;   Drug: Ranibizumab
29 Unknown  Intravitreal Bevacizumab for Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: bevacizumab intravitreal injection
30 Recruiting S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
Conditions: Cataract;   Macular Degeneration
Interventions: Drug: selenium;   Drug: vitamin E;   Drug: vitamin E placebo;   Drug: selenium placebo
31 Recruiting Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Device: Telescope prosthesis;   Device: WA-NG Telescope Prothesis
32 Recruiting Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration
Condition: Age Related Macular Degeneration and Stargartd
Intervention: Other: intravitreal injection of autologous bone marrow stem cells
33 Recruiting Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration
Conditions: Depression;   Age-related Macular Degeneration
Intervention: Behavioral: Self-Care Tools
34 Unknown  Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab
35 Recruiting Laser Intervention in Early Age-Related Macular Degeneration Study
Condition: Age-related Macular Degeneration
Intervention: Device: 2RT nanosecond laser
36 Recruiting Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy
Condition: Age-related Macular Degeneration
37 Recruiting A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
Conditions: Diabetic Macular Edema;   Age-related Macular Degeneration
Intervention: Drug: MTP-131
38 Recruiting Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Monthly Ranibizumab Injections
Condition: Age Related Macular Degeneration
Intervention: Drug: Aflibercept
39 Recruiting Non-exudative Age-related Macular Degeneration
Condition: Non-exudative Age-related Macular Degeneration
40 Recruiting Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration
Condition: Wet Age-related Macular Degeneration
Intervention: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years